NTI
Click for more information
2.78% 7.0¢ neurotech international limited

Ann: Last Patient Completes Treatment in NTIASD2 Clinical Trial, page-3

  1. Scrooge1
    225 Posts.
    lightbulb Created with Sketch. 65
    clock Created with Sketch.
    10/04/24
    08:45
    Post #: 73269145
    "The results of the NTIASD2 clinical trial are expected in early Q2 CY2024."

    Not long to go now! Should be in the next few of weeks.
    NTI Price at posting: 10.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
-0.002(2.78%) 		Mkt cap ! $71.21M
Open High Low Value Volume
7.3¢ 7.3¢ 7.0¢ $86.59K 1.228M

Buyers (Bids)

No. Vol. Price($)
1 6000 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 72226 1
View Market Depth
Last trade - 15.38pm 28/06/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.